Parian Global Management’s The Oncology Institute TOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.11M Buy
240,724
+56,896
+31% +$335K 3.63% 9
2022
Q2
$930K Sell
183,828
-260,416
-59% -$1.9M 4.26% 11
2022
Q1
$3.17M Sell
444,244
-22,432
-5% -$151K 6.53% 6
2021
Q4
$4.55M Buy
+466,676
New +$4.15M 3.65% 9

Other funds holding TOI

Parian Global Management's TOI Position: Q3 2022 in Review

Parian Global Management increased its The Oncology Institute (TOI) stake by 31% in Q3 2022, buying an estimated $335K and bringing the position to 240,724 shares worth $1.11M. The position accounts for 3.63% of the portfolio, ranked #9.

Parian Global Management first reported a position in TOI in Q4 2021 and has held it in 4 quarters since. The position peaked at $4.55M in Q4 2021. 39 funds tracked by Wall St. Rank hold TOI as of Q3 2022.

  • Parian Global Management held 240,724 shares of The Oncology Institute worth $1.11M as of Q3 2022.
  • Parian Global Management bought 56,896 The Oncology Institute shares in Q3 2022, an estimated $335K.
  • The Oncology Institute made up 3.63% of Parian Global Management's portfolio in Q3 2022, its #9 holding.
  • Parian Global Management first reported a position in The Oncology Institute in Q4 2021 and has held it in 4 quarters since.
  • Parian Global Management's The Oncology Institute position peaked at $4.55M in Q4 2021.
  • 39 funds tracked by Wall St. Rank held The Oncology Institute as of Q3 2022.

Based on Parian Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.